Monitor proxy vote outcome on June 18, 2026 — failure to approve the equity plan would force cash-based compensation, pressuring liquidity. Stockholder sentiment on the plan is the key near-term catalyst.
Price Chart
Executive Summary
OPKO Health filed a DEFA14A supplement clarifying that its 2016 Equity Incentive Plan expired in February 2026, rendering 19,008,162 previously available shares no longer grantable. The board reaffirms its recommendation to approve the new 2026 Equity Incentive Plan at the June 18, 2026 annual meeting; failure to pass would halt equity grants, potentially increasing cash compensation and reducing cash for operations.
Key Facts
- 2016 Equity Incentive Plan expired February 2026; 19,008,162 shares no longer available for grant.
- Board recommends voting FOR the 2026 Equity Incentive Plan at the June 18, 2026 annual meeting.
- If plan not approved, OPKO cannot grant new equity awards, may shift to cash compensation, reducing cash for operations.
- Supplement clarifies prior proxy statement; no other changes to proposals.
Financial Impact
No specific dollar amounts disclosed; potential shift to cash compensation if plan fails could reduce operating cash, but magnitude unquantified.
Risk Factors
- Stockholders may reject the 2026 Equity Incentive Plan, halting equity grants and increasing cash compensation costs.
- Increased cash compensation could reduce cash available for operations and R&D.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-227011 |
| Document: 0001193125-26-227011-index-headers.html | 0001193125-26-227011 |
| Document: 0001193125-26-227011-index.html | 0001193125-26-227011 |
| Document: 0001193125-26-227011.txt | 0001193125-26-227011 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 27, 2026 9w ago | 8-K | $1.65 $1.49 | ▼ −9.70% | ▼ −13.08% | $1.56 (−5.45%) |
Jul 23, 2026 10w ago | Press Release | $1.17 $1.46 | ▲ +24.79% | ▲ +21.48% | $1.56 (+33.33%) |
Jun 15, 2026 15w ago | Press Release | $1.40 $1.23 | ▼ −12.14% | ▼ −11.39% | $1.56 (+11.43%) |
May 15, 2026 19w ago | DEFA14A | $1.13 $1.39 | ▲ +23.01% | ▲ +21.43% | $1.56 (+38.05%) |
Apr 30, 2026 22w ago | Press Release | $1.13 $1.43 | ▲ +26.55% | ▲ +21.58% | $1.56 (+38.05%) |
Apr 22, 2026 23w ago | Press Release | $1.23 $1.15 | ▼ −6.50% | ▼ −9.67% | $1.56 (+26.83%) |
Apr 21, 2026 23w ago | Press Release | $1.23 $1.15 | ▼ −6.50% | ▼ −9.67% | $1.56 (+26.83%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access